A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 287 participants.
Also called NCT01218204
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 287 participants
- Sponsor
- Registry
-
NCT01218204
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01218204. Randomized; triple masking; primary purpose treatment. Start 2010-09-14 (actual); primary completion 2011-06-29 (actual). Results posted on 2017-11-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin
- Condition
- Dyslipidaemias
- Condition
- Dyslipidemias
- Intervention (Drug)
- 10mg atorvastatin
- Intervention (Drug)
- 80mg atorvastatin
- Intervention (Drug)
- GSK1292263 Placebo
- Intervention (Drug)
- 100mg GSK1292263
- Intervention (Drug)
- 300mg GSK1292263
- Intervention (Drug)
- 800mg GSK1292263
- Intervention (Drug)
- 10mg ezetimibe
- Intervention (Other)
- Washout
- Lead sponsor
- GlaxoSmithKline
Record details
- Record id
cardio:ct-nct01218204- Content hash
f12ff4df593fdde97dad8dfe8b0f86f6e21da2b804287cf47100fc908d993158